» Articles » PMID: 18287069

Single Gene Reassortants Identify a Critical Role for PB1, HA, and NA in the High Virulence of the 1918 Pandemic Influenza Virus

Overview
Specialty Science
Date 2008 Feb 22
PMID 18287069
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

The 1918 influenza pandemic was exceptionally severe, resulting in the death of up to 50 million people worldwide. Here, we show which virus genes contributed to the replication and virulence of the 1918 influenza virus. Recombinant viruses, in which genes of the 1918 virus were replaced with genes from a contemporary human H1N1 influenza virus, A/Texas/36/91 (Tx/91), were generated. The exchange of most 1918 influenza virus genes with seasonal influenza H1N1 virus genes did not alter the virulence of the 1918 virus; however, substitution of the hemagglutinin (HA), neuraminidase (NA), or polymerase subunit PB1 genes significantly affected the ability of this virus to cause severe disease in mice. The 1918 virus virulence observed in mice correlated with the ability of 1918 recombinant viruses to replicate efficiently in human airway cells. In a second series of experiments, eight 1918 1:7 recombinants were generated, in which each Tx/91 virus gene was individually replaced by a corresponding gene from 1918 virus. Replication capacity of the individual 1:7 reassortant viruses was assessed in mouse lungs and human airway cells. Increased virus titers were observed among 1:7 viruses containing individual 1918 HA, NA, and PB1 genes. In addition, the 1918 PB1:Tx/91 (1:7) virus showed a distinctly larger plaque size phenotype than the small plaque phenotype of the 1918 PA:Tx/91 and 1918 PB2:Tx/91 1:7 reassortants. These results highlight the importance of the 1918 HA, NA, and PB1 genes for optimal virus replication and virulence of this pandemic strain.

Citing Articles

Effect of pandemic influenza A virus PB1 genes of avian origin on viral RNA polymerase activity and pathogenicity.

Williams S, Qi L, Sheng Z, Xiao Y, Freeman A, Matthews L Sci Adv. 2024; 10(50):eads5735.

PMID: 39671482 PMC: 11641000. DOI: 10.1126/sciadv.ads5735.


Highly Pathogenic Avian Influenza (HPAI) H5 Clade 2.3.4.4b Virus Infection in Birds and Mammals.

Graziosi G, Lupini C, Catelli E, Carnaccini S Animals (Basel). 2024; 14(9).

PMID: 38731377 PMC: 11083745. DOI: 10.3390/ani14091372.


Mammalian adaptation risk in HPAI H5N8: a comprehensive model bridging experimental data with mathematical insights.

Chokkakula S, Oh S, Choi W, Kim C, Jeong J, Kim B Emerg Microbes Infect. 2024; 13(1):2339949.

PMID: 38572657 PMC: 11022924. DOI: 10.1080/22221751.2024.2339949.


Deep mutational scanning reveals the functional constraints and evolutionary potential of the influenza A virus PB1 protein.

Li Y, Arcos S, Sabsay K, Te Velthuis A, Lauring A J Virol. 2023; 97(11):e0132923.

PMID: 37882522 PMC: 10688322. DOI: 10.1128/jvi.01329-23.


History of advances in genetic engineering of viruses before COVID-19 pandemic.

Teppone M Surg Neurol Int. 2023; 14:109.

PMID: 37025520 PMC: 10070288. DOI: 10.25259/SNI_36_2023.


References
1.
Tumpey T, Maines T, Van Hoeven N, Glaser L, Solorzano A, Pappas C . A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science. 2007; 315(5812):655-9. DOI: 10.1126/science.1136212. View

2.
Webby R, Webster R . Are we ready for pandemic influenza?. Science. 2003; 302(5650):1519-22. DOI: 10.1126/science.1090350. View

3.
Taubenberger J . The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc. 2007; 150(1):86-112. PMC: 2720273. View

4.
Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S . Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol. 2007; 81(22):12439-49. PMC: 2169033. DOI: 10.1128/JVI.01134-07. View

5.
Temonen M, Vapalahti O, Holthofer H, BRUMMER-KORVENKONTIO M, Vaheri A, Lankinen H . Susceptibility of human cells to Puumala virus infection. J Gen Virol. 1993; 74 ( Pt 3):515-8. DOI: 10.1099/0022-1317-74-3-515. View